Ultragenyx Pharmaceutical (RARE) EBT Margin Growth (3y) (2019 - 2026)
Ultragenyx Pharmaceutical (RARE) EBT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 49,756.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 441.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ultragenyx Pharmaceutical | 2.77 Bn | 2.36 Bn | 106.00 Mn | 2,738.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,738.00 |
| Dec 31, 2025 | 8,672.00 |
| Sep 30, 2025 | 15,104.00 |
| Jun 30, 2025 | 10,822.00 |
| Mar 31, 2025 | 8,194.00 |
| Dec 31, 2024 | 41,090.00 |
| Sep 30, 2024 | -631.00 |
| Jun 30, 2024 | 5,131.00 |
| Mar 31, 2024 | -1,982.00 |
| Dec 31, 2023 | -7,407.00 |
| Sep 30, 2023 | -7,804.00 |
| Jun 30, 2023 | -18,859.00 |
| Mar 31, 2023 | 16,401.00 |
| Dec 31, 2022 | 10,804.00 |
| Sep 30, 2022 | 17,353.00 |
| Jun 30, 2022 | 23,310.00 |
| Mar 31, 2022 | 34,140.00 |
| Dec 31, 2021 | 38,970.00 |
| Sep 30, 2021 | 65,096.00 |
| Jun 30, 2021 | 27,110.00 |